Search research articles
Contact Us
Filters
Showing results (31-40 of 49) with videos related to
Page
of 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
September 18, 1997
Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis
Q Xiao, M J Danton, D P Witte, et al.
The American Journal of Pathology
|
March 10, 2001
Plasminogen activators direct reorganization of the liver lobule after acute injury
J A Bezerra, A R Currier, H Melin-Aldana, et al.
The EMBO Journal
|
April 1, 1993
Unliganded T3R, but not its oncogenic variant, v-erbA, suppresses RAR-dependent transactivation by titrating out RXR
D Barettino, T H Bugge, P Bartunek, et al.
Blood
|
March 21, 1998
Ligneous conjunctivitis in plasminogen-deficient mice
A F Drew, A H Kaufman, K W Kombrinck, et al.
Blood
|
November 9, 2000
Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells
J S Palumbo, K W Kombrinck, A F Drew, et al.
Thrombosis and Haemostasis
|
April 4, 2014
Potent and specific inhibition of the biological activity of the type-II transmembrane serine protease matriptase by the cyclic microprotein MCoTI-II
K Gray, S Elghadban, P Thongyoo, et al.
Journal of Virology
|
September 1, 1990
Analysis of a highly immunodominant epitope in the human immunodeficiency virus type 1 transmembrane glycoprotein, gp41, defined by a human monoclonal antibody
T H Bugge, B O Lindhardt, L L Hansen, et al.
The EMBO Journal
|
September 2, 1999
Functional overlap between two classes of matrix-degrading proteases in wound healing
L R Lund, J Romer, T H Bugge, et al.
Oncogene
|
January 11, 2011
c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase
R Szabo, A L Rasmussen, A B Moyer, et al.
The Journal of Biological Chemistry
|
July 14, 1995
The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility
T H Bugge, T T Suh, M J Flick, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 49) with videos related to
Sort By:
Page
of 5
Proceedings of the National Academy of Sciences of the United States of America
|
September 18, 1997
Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis
Q Xiao, M J Danton, D P Witte, et al.
The American Journal of Pathology
|
March 10, 2001
Plasminogen activators direct reorganization of the liver lobule after acute injury
J A Bezerra, A R Currier, H Melin-Aldana, et al.
The EMBO Journal
|
April 1, 1993
Unliganded T3R, but not its oncogenic variant, v-erbA, suppresses RAR-dependent transactivation by titrating out RXR
D Barettino, T H Bugge, P Bartunek, et al.
Blood
|
March 21, 1998
Ligneous conjunctivitis in plasminogen-deficient mice
A F Drew, A H Kaufman, K W Kombrinck, et al.
Blood
|
November 9, 2000
Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells
J S Palumbo, K W Kombrinck, A F Drew, et al.
Thrombosis and Haemostasis
|
April 4, 2014
Potent and specific inhibition of the biological activity of the type-II transmembrane serine protease matriptase by the cyclic microprotein MCoTI-II
K Gray, S Elghadban, P Thongyoo, et al.
Journal of Virology
|
September 1, 1990
Analysis of a highly immunodominant epitope in the human immunodeficiency virus type 1 transmembrane glycoprotein, gp41, defined by a human monoclonal antibody
T H Bugge, B O Lindhardt, L L Hansen, et al.
The EMBO Journal
|
September 2, 1999
Functional overlap between two classes of matrix-degrading proteases in wound healing
L R Lund, J Romer, T H Bugge, et al.
Oncogene
|
January 11, 2011
c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase
R Szabo, A L Rasmussen, A B Moyer, et al.
The Journal of Biological Chemistry
|
July 14, 1995
The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility
T H Bugge, T T Suh, M J Flick, et al.
Page
of 5